Hosted on MSN6mon
Immunai, AstraZeneca collaborate to optimize cancer clinical trialsthe Immunodynamics Engine (IDE)™. Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback